scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.ATV.11.1.174 |
P698 | PubMed publication ID | 1987996 |
P50 | author | Anders Hamsten | Q30421754 |
P2093 | author name string | J Johansson | |
L A Carlson | |||
C Landou | |||
P433 | issue | 1 | |
P304 | page(s) | 174-182 | |
P577 | publication date | 1991-01-01 | |
P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
P1476 | title | High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients | |
P478 | volume | 11 |
Q34559952 | A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice |
Q35749303 | APOA1 gene polymorphisms in the South Asian immigrant population in the United States. |
Q37074030 | APOE genotype affects black-white responses of high-density lipoprotein cholesterol subspecies to aerobic exercise training |
Q73450272 | Alterations in plasma lipids, lipoproteins and high density lipoprotein subfractions in peripheral arterial disease |
Q44451323 | Alterations of HDL subclasses in hyperlipidemia |
Q79376410 | Alterations of high density lipoprotein subclasses in obese subjects |
Q34348277 | Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a pilot study. |
Q46170654 | Associations of genetic variants in ATP-binding cassette A1 and cholesteryl ester transfer protein and differences in lipoprotein subclasses in the multi-ethnic study of atherosclerosis |
Q43719828 | Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease |
Q68226787 | Close correlation between high-density lipoprotein and triglycerides in normotriglyceridaemia |
Q33795981 | Comparison of Postprandial Responses to a High-Fat Meal in Hypertriglyceridemic Men and Women before and after Treatment with Fenofibrate in the Genetics and Lipid Lowering Drugs and Diet Network (GOLDN) Study. |
Q46561056 | Comparison of high-density and low-density lipoprotein cholesterol subclasses and sizes in Asian Indian women with Caucasian women from the Framingham Offspring Study. |
Q37440932 | Coronary artery endothelial dysfunction is positively correlated with low density lipoprotein and inversely correlated with high density lipoprotein subclass particles measured by nuclear magnetic resonance spectroscopy |
Q57337160 | Dietary fat saturation distinctly affects apolipoprotein gene expression and high density lipoprotein size distribution in two strains of Golden Syrian hamsters |
Q51166724 | Early atherogenesis and visceral fat in obese adolescents. |
Q37189976 | Effect of dehydroepiandrosterone replacement on lipoprotein profile in hypoadrenal women. |
Q43687599 | Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia |
Q44317936 | Effects of bezafibrate and pravastatin on remnant-like lipoprotein particles and lipoprotein subclasses in type 2 diabetes |
Q37307972 | Effects of exercise on lipoprotein particles in women with polycystic ovary syndrome |
Q44476840 | Effects of extended-release niacin on lipoprotein subclass distribution |
Q43833266 | Effects of pravastatin treatment on lipoprotein subclass profiles and particle size in the PLAC-I trial |
Q71858808 | Effects of simvastatin on plasma lipoprotein subfractions, cholesterol esterification rate, and cholesteryl ester transfer protein in type II hyperlipoproteinemia |
Q33727998 | Endurance exercise training effects on body fatness, VO2max, HDL-C subfractions, and glucose tolerance are influenced by a PLIN haplotype in older Caucasians |
Q38293451 | Epidemiology: disease associations and modulators of HDL-related biomarkers |
Q74046180 | Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein |
Q44631872 | Fractional Esterification Rate of Cholesterol and Ratio of Triglycerides to HDL-Cholesterol Are Powerful Predictors of Positive Findings on Coronary Angiography |
Q37048418 | HDL heterogeneity and coronary heart disease |
Q43889901 | HDL particle size: a marker of the gender difference in the metabolic risk profile |
Q45936247 | HDL subspecies in young adult twins: heritability and impact of overweight. |
Q26775420 | High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk |
Q33737098 | High-density lipoprotein particle subclass heterogeneity and incident coronary heart disease |
Q36959779 | High-density lipoprotein subfractions and carotid plaque: the Northern Manhattan Study. |
Q51552490 | Hypercholesterolemia and Dyslipidemia. |
Q51537186 | Hypercholesterolemia and Dyslipidemia: Issues for the Clinician. |
Q37786770 | Hypertriglyceridaemia, triglyceride-rich lipoproteins and coronary heart disease |
Q51557580 | Impact of insulin resistance on lipoprotein subpopulation distribution in lean and morbidly obese nondiabetic women. |
Q44097757 | Influences of the PPAR alpha-L162V polymorphism on plasma HDL(2)-cholesterol response of abdominally obese men treated with gemfibrozil |
Q37401325 | Lipoprotein lipase and hepatic lipase: their relationship with HDL subspecies Lp(A-I) and Lp(A-I,A-II). |
Q37089542 | Lipoprotein particle distribution and size, insulin resistance, and metabolic syndrome in Alaska Eskimos: the GOCADAN study |
Q36763277 | Lipoprotein subclasses in genetic studies: the Berkeley data set. |
Q30514016 | Lipoprotein subfractions and dietary intake of n-3 fatty acid: the Genetics of Coronary Artery Disease in Alaska Natives study |
Q46904300 | Lipoprotein subpopulation distributions in lean, obese, and type 2 diabetic women: a comparison of African and white Americans |
Q34990610 | Measurement issues related to lipoprotein heterogeneity |
Q33665252 | Measurement of triglyceride-rich lipoproteins by nuclear magnetic resonance spectroscopy |
Q56091366 | Measurement of triglyceride-rich lipoproteins by nuclear magnetic resonance spectroscopy |
Q43687592 | Metabolic disorders contribute to subclinical coronary atherosclerosis in patients with coronary calcification. |
Q40343323 | Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein |
Q33820345 | Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile |
Q44647368 | Once‐Daily Niacin Extended Release/Lovastatin Combination Tablet Has More Favorable Effects on Lipoprotein Particle Size and Subclass Distribution Than Atorvastatin and Simvastatin |
Q47326493 | Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patients |
Q43545506 | Oral 17beta-estradiol and medroxyprogesterone acetate therapy in postmenopausal women increases HDL particle size |
Q47987181 | Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men. |
Q49554117 | Pharmacological Intervention to Modulate HDL: What Do We Target? |
Q54120058 | Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility. |
Q25255948 | Plasma LDL and HDL characteristics and carotenoid content are positively influenced by egg consumption in an elderly population |
Q47644677 | Premature Coronary Heart Disease in South Asians: Burden and Determinants |
Q36297930 | Preparation and activity analysis of recombinant human high-density lipoprotein |
Q34003407 | Preventing, stopping, or reversing coronary artery disease--triglyceride-rich lipoproteins and associated lipoprotein and metabolic abnormalities: the need for recognition and treatment |
Q33859347 | Prevention of coronary heart disease. Part I. Primary prevention |
Q37205985 | Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort |
Q77330990 | Randomized controlled trial of gamma-linolenic acid and eicosapentaenoic acid in peripheral arterial disease |
Q37661249 | Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL. |
Q68231218 | Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease |
Q44054640 | Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial |
Q73229439 | Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women |
Q34732457 | Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease |
Q85811975 | Statin treatment improves plasma lipid levels but not HDL subclass distribution in patients undergoing percutaneous coronary intervention |
Q90224960 | The Burden of Atherosclerotic Cardiovascular Disease in South Asians Residing in Canada: A Reflection From the South Asian Heart Alliance |
Q37041300 | The Pleiotropic Effects of Atorvastatin on Stable Angina Patients: Evidence by Analysis of High-Density Lipoprotein Size and Subclasses, and Plasma mRNA. |
Q33681012 | The associations of high-density lipoprotein subclasses with insulin and glucose levels, physical activity, resting heart rate, and regional adiposity in men with coronary artery disease: the Stanford Coronary Risk Intervention Project baseline surv |
Q79280417 | The effect of a rapid weight loss on lipid profile and glycemic control in obese type 2 diabetic patients |
Q34564466 | The impact of plasma triglyceride and apolipoproteins concentrations on high-density lipoprotein subclasses distribution |
Q42797558 | The isolation and characterization of high-density-lipoprotein subfractions containing apolipoprotein E from human plasma |
Q35017376 | The physiology of lipoproteins |
Q44804722 | The protective effects of HDL and its constituents against neutrophil respiratory burst activation by hypochlorite-oxidized LDL. |
Q47772676 | The role of cholesteryl ester transfer protein and phospholipid transfer protein in the remodeling of plasma high-density lipoproteins |
Q41282607 | Uptake of apolipoprotein E-rich and apolipoprotein E-poor subfractions of high-density lipoprotein by liver membranes and HepG2 cells |
Q44316273 | Visualization of the uptake of high-density lipoprotein by rat aortic endothelial cells and smooth muscle cells in vitro |
Search more.